Neuropsychiatric Disease and Treatment (Jun 2024)

Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!

  • Yoldi-Negrete M,
  • Fresán A,
  • Jiménez-Rodríguez LI,
  • Tirado-Durán EG

Journal volume & issue
Vol. Volume 20
pp. 1181 – 1189

Abstract

Read online

María Yoldi-Negrete,1 Ana Fresán,1 Laura Ivone Jiménez-Rodríguez,2 Elsa Georgina Tirado-Durán2 1Clinical Epidemiology Laboratory, Clinical Research Directorate, Ramón de la Fuente Muñiz National Institute of Psychiatry, Mexico City, Mexico; 2Department of Psychology, Neuropsychology, Clinical Services Directorate, Ramón de la Fuente Muñiz National Institute of Psychiatry, Mexico City, MexicoCorrespondence: María Yoldi-Negrete, Email [email protected]; [email protected]: Despite the high prevalence of anxiety disorders in BD and its known impact on cognitive performance, the presence and severity of anxious symptoms is not systematically evaluated in studies on cognition in BD. Our aim was to determine if attention and/or inhibition of cognitive interference in euthymic patients with type I Bipolar Disorder (BD-I) is affected by symptoms of anxiety.Patients and Methods: Eighty-seven euthymic BD-I patients were included. Patients with comorbidities other than Generalized Anxiety Disorder (GAD) or Panic Disorder (PD) were excluded. State anxiety was measured with the Brief Inventory of Anxious Responses and Situations (ISRA-B). Subjective cognitive performance was evaluated with the COBRA scale, attention with the Digit-Span Forward task and inhibition of cognitive interference was assessed with the StroopTest interference score. Multiple linear regression models were used to test if anxious symptoms were associated with attention or inhibition of cognitive interference, considering other known contributors for cognitive impairment.Results: Attention was unaffected by anxiety symptoms, but the overall regression for inhibition of cognitive interference was significant: years of schooling (β=1.12, p = 0.001), cognitive complaints (β=0.44, p = 0.008), and anxiety (β=− 0.21, p = 0.017) explained 15% of the interference score of the Stroop test (R2 = 0.15).Conclusion: Beyond residual affective symptoms, anxious symptoms seem to affect inhibition of cognitive interference. We recommend routine testing of anxiety when considering cognitive evaluations, especially when screening for cognitive deficits.Keywords: anxiety, attention, digit span forward, cognitive interference, Stroop effect, bipolar-I disorder, comorbid

Keywords